An intermediate in the synthesis of PDE-1 inhibitors, used in therapy for parkinson’s disease, depression and narcolepsy.
Uses
7-[(4-Methoxyphenyl)Methyl]-5-Methyl-2H-pyrazolo[3,4-d]pyriMidine-4,6(5H,7H)-dione is an intermediate in the synthesis of PDE-1 inhibitors, used in therapy for parkinson’s disease, depression and narcolepsy.
![7-[(4-Methoxyphenyl)Methyl]-5-Methyl-2H-pyrazolo[3,4-d]pyriMidine-4,6(5H,7H)-dione Structure](/CAS/GIF/1351961-59-5.gif)